Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015
HUANG, Daniel; BOGAERTS, Pierre; BEHRIN, C.et al.
2017 • In Euro Surveillance: Bulletin Européen sur les Maladies Transmissibles, 22 (19)
Epidemiology; carbapenem resistance; colistine resistance; community
Abstract :
[en] Carbapenemase-producing Enterobacteriaceae (CPE) strains have been increasingly reported in Belgium. We aimed to determine the proportion of CPE among Enterobacteriaceae isolated from hospitalised patients and community outpatients in Belgium in 2015. For the hospitalised patients, the results were compared to a previous similar survey performed in the same hospitals in 2012. Twenty-four hospital-based and 10 private laboratories collected prospectively 200 non-duplicated Enterobacteriaceae isolates from clinical specimens. All isolates were screened locally by carbapenem disk diffusion using European Committee on Antimicrobial Susceptibility Testing methodology. Putative CPE strains with inhibition zone diameters below the screening breakpoints were referred centrally for confirmation of carbapenemase production. From September to November 2015, we found a proportion of clinical CPE of 0.55% (26/4,705) and of 0.60% (12/1,991) among hospitalised patients and among ambulatory outpatients respectively. Klebsiella pneumoniae (26/38) and OXA-48-like carbapenemase (28/38) were the predominant species and enzyme among CPE. One OXA-48-producing Escherichia coli isolated from a hospital was found carrying plasmid-mediated MCR-1 colistin resistance. Compared with the 2012 survey, we found a significant increased proportion of clinical CPE (0.55% in 2015 vs 0.25% in 2012; p = 0.02) and an increased proportion of hospitals (13/24 in 2015 vs 8/24 in 2012) with at least one CPE detected. The study results confirmed the concerning spread of CPE including a colistin-resistant MCR-1 producer in hospitals and the establishment of CPE in the community in Belgium.
Research Center/Unit :
Centre Interfacultaire de Recherche du Médicament - CIRM
Disciplines :
Immunology & infectious disease Public health, health care sciences & services Laboratory medicine & medical technology
Author, co-author :
HUANG, Daniel
BOGAERTS, Pierre
BEHRIN, C.
HOEBEKE, M.
BAURAING, C.
GLUPCZYNSKI, Youri
MELIN, Pierrette ; Centre Hospitalier Universitaire de Liège - CHU > Service de microbiologie clinique
Multicentre study group, .
Language :
English
Title :
Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015
Publication date :
May 2017
Journal title :
Euro Surveillance: Bulletin Européen sur les Maladies Transmissibles
ISSN :
1025-496X
eISSN :
1560-7917
Publisher :
Centre Europeen pour la Surveillance Épidemiologique du SIDA, France
Volume :
22 (19)
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
Belgian Ministry of Social Affairs BAPCOC - Belgian Antibiotic Policy Coordination Committee
Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae.Emerg Infect Dis. 2011;17(10):1791-8. DOI: 10.3201/eid1710.110655 PMID: 22000347
Nordmann P, Cornaglia G. Carbapenemase-producing Enterobacteriaceae: a call for action!Clin Microbiol Infect. 2012;18(5):411-2. DOI: 10.1111/j.1469-0691.2012.03795.x PMID: 22507108
Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al., European Network on Carbapenemases. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.Clin Microbiol Infect. 2012;18(5):413-31. DOI: 10.1111/j.1469-0691.2012.03821.x PMID: 22507109
Oteo J, Ortega A, Bartolomé R, Bou G, Conejo C, Fernández-Martínez M, et al., GEIH-GEMARA (SEIMC) and REIPI. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem. Antimicrob Agents Chemother. 2015;59(6):3406-12. DOI: 10.1128/AAC.00086-15 PMID: 25824224
Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL, European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill. 2015;20(45):30062. DOI: 10.2807/1560-7917. ES2013.18.28.20525 PMID: 23870096
Huang TD, Berhin C, Bogaerts P, Glupczynski Y, multicentre study group. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium. J Antimicrob Chemother. 2013;68(8):1832-7. DOI: 10.1093/jac/dkt096 PMID: 23557926
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: Twenty-Second Informational Supplement M100-S22. Wayne, PA: CLSI; 2012.
Huang TD, Bogaerts P, Berhin C, Jans B, Denis O, Glupczynski Y, editors. National survey data of carbapenemase-producing Enterobacteriaceae in Belgium. In: Abstracts of the 25th European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen; 2015. Abstract no O374.
European Society of Clinical Microbiology and Infectious Diseases. Clinical breakpoints version 5.0. In European Committee on Antimicrobial Susceptibility Testing. Växjö: EUCAST; 2015. Available from: http://www.eucast.org
European Society of Clinical Microbiology and Infectious Diseases. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 1.0. Växjö: EUCAST; 2013. Available from: http://www.eucast.org
Bogaerts P, Yunus S, Massart M, Huang TD, Glupczynski Y. Evaluation of the BYG Carba Test, a New Electrochemical Assay for Rapid Laboratory Detection of Carbapenemase-Producing Enterobacteriaceae. J Clin Microbiol. 2016;54(2):349-58. DOI: 10.1128/JCM.02404-15 PMID: 26637378
Bogaerts P, Rezende de Castro R, de Mendonça R, Huang TD, Denis O, Glupczynski Y. Validation of carbapenemase and extended-spectrum β-lactamase multiplex endpoint PCR assays according to ISO 15189.J Antimicrob Chemother. 2013;68(7):1576-82. DOI: 10.1093/jac/dkt065 PMID: 23508620
Lahey clinic. ß-Lactamase Classification and Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant Enzymes. Available from: http://www.lahey. org/Studies/
Fuchs PC, Barry AL, Thornsberry C, Jones RN. Interpretive criteria for temocillin disk diffusion susceptibility testing.Eur J Clin Microbiol. 1985;4(1):30-3. DOI: 10.1007/BF02148656 PMID: 3872793
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161-8. DOI: 10.1016/S1473-3099(15)00424-7 PMID: 26603172
Deplano A, Denis O, Rodriguez-Villalobos H, De Ryck R, Struelens MJ, Hallin M. Controlled performance evaluation of the DiversiLab repetitive-sequence-based genotyping system for typing multidrug-resistant health care-associated bacterial pathogens.J Clin Microbiol. 2011;49(10):3616-20. DOI: 10.1128/JCM.00528-11 PMID: 21813717
Jans B, D Huang TD, Bauraing C, Berhin C, Bogaerts P, Deplano A, et al. Infection due to travel-related carbapenemase-producing Enterobacteriaceae, a largely underestimated phenomenon in Belgium. Acta Clin Belg. 2015;70(3):181-7. DOI: 10.1179/2295333715Y.0000000001 PMID: 25825036
Parisi SG, Bartolini A, Santacatterina E, Castellani E, Ghirardo R, Berto A, et al. Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014. BMC Infect Dis. 2015;15(1):244. DOI: 10.1186/s12879-015-0996-7 PMID: 26116560
Huang TD, Bogaerts P, Berhin C, Boucharhouf W, Glupczynski Y, editors. Susceptibility data of Enterobacteriaceae isolates referred to the national reference center in Belgium. In: Abstracts of the 35th Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse, Paris; 2015. Abstract no O113.
Poirel L, Kieffer N, Liassine N, Thanh D, Nordmann P. Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli.Lancet Infect Dis. 2016;16(3):281. DOI: 10.1016/S1473-3099(16)00006-2 PMID: 26774246
Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill. 2016;21(9):30155. DOI: 10.2807/1560-7917. ES.2016.21.9.30155 PMID: 26967914
Yao X, Doi Y, Zeng L, Lv L, Liu JH. Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1.Lancet Infect Dis. 2016;16(3):288-9. DOI: 10.1016/S1473-3099(16)00057-8 PMID: 26842777
Miró E, Agüero J, Larrosa MN, Fernández A, Conejo MC, Bou G, et al. Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur J Clin Microbiol Infect Dis. 2013;32(2):253-9.PMID: 22956023
Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, et al. High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics. Clin Infect Dis. 2015;61(4):593-600. DOI: 10.1093/cid/civ333 PMID: 25904368
Voulgari E, Poulou A, Dimitroulia E, Politi L, Ranellou K, Gennimata V, et al. Emergence of OXA-162 Carbapenemase-and DHA-1 AmpC Cephalosporinase-Producing Sequence Type 11 Klebsiella pneumoniae Causing Community-Onset Infection in Greece. Antimicrob Agents Chemother. 2015;60(3):1862-4. DOI: 10.1128/AAC.01514-15 PMID: 26666930
Zurfluh K, Nüesch-Inderbinen MT, Poirel L, Nordmann P, Hächler H, Stephan R. Emergence of Escherichia coli producing OXA-48 β-lactamase in the community in Switzerland. Antimicrob Resist Infect Control. 2015;4(1):9. DOI: 10.1186/s13756-015-0051-x PMID: 25834728
Yusuf E, Huang TD, Schallier A, Trémérie JM, Mertens R, Jans B, et al. OXA-48 Producing Klebsiella pneumoniae in a Household Contact of a Previously Infected Patient: Person-to-Person Transmission or Coincidental Community Acquisition? Microb Drug Resist. 2016;22(2):134-6. DOI: 10.1089/mdr.2015.0179 PMID: 26954370
